Axira by NexushriLabs
Axira is a drug intelligence suite, currently in stealth.
Built for pharmaceutical scientists, clinical researchers, and drug development teams who need more from their data than current tools provide, Axira brings together AI-powered intelligence across the drug development lifecycle, from biological signal detection and multi-omic biomarker discovery to clinical data intelligence, sample management, and drug target identification. Each capability is independently deployable and designed to work within the data integrity and regulatory standards that govern serious pharmaceutical research.
Where most platforms offer analytics, Axira offers answers. Validated, explainable, and traceable to the source. It is built by scientists who have worked inside the problems it solves.
Launching soon. If you are in pharmaceutical research, drug discovery, or clinical operations and want to be among the first to access early capabilities, we would like to hear from you.
Request early accessOne architecture.
Every platform.
The NexushriLabs stack was designed for regulated data from the start. Validated inputs, traceable reasoning, and auditable outputs are not features added after the fact. They are how the system is built. Each platform in the portfolio runs on the same underlying architecture, which means the compliance properties are consistent across the suite.
The work is underway.
NexushriLabs formed in February 2026. Since then the company has filed for federal grant eligibility, submitted to ARPA-H, established business banking, and built out the platform portfolio. The milestones below cover the first five months of operation.
Socioeconomic representations made by the company in the System for Award Management. Self-certified status, not issued by a certifying authority.
Applications will be submitted to SBA following completion of SAM.gov registration.
Announcements
Three Solution Summaries submitted to ARPA-H under the 2026 SBIR solicitation, covering women's health and safety science applications.
Nexushri LLC has been assigned a Unique Entity Identifier in the System for Award Management. Registration is in progress.
The science is real.
The platforms are built.
NexushriLabs is founded and led by Jayashri Prasanan, a doctoral scientist, builder, and entrepreneur with deep knowledge of regulatory science, GxP frameworks, and the structural gaps in how software serves pharma, biotech, life sciences, and healthcare.
“NexushriLabs exists because the pain points were real and the solutions were not.”
Jayashri Prasanan, Founder & CEO
Why NexushriLabs
Talk to us.
Whether you are exploring a pilot, considering an investment, looking for a research partner, or have a question about the platform portfolio, reach out directly.